Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-09-08

FDA Approved: ESCITALOPRAM — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for escitalopram oxalate from Sun Pharmaceutical Industries, Inc., indicating approval of a generic escitalopram pro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Escitalopram (escitalopram)

Snippet

SUPPL AP for ESCITALOPRAM (ESCITALOPRAM OXALATE)